Inaugural Female Founders Day

Miranda helps early-stage biomedical businesses attract investment and develop their business strategy. She founded BioBeat to spur entrepreneurial growth in life sciences and connect entrepreneurs with leaders in the sector.

She has worked with many entrepreneurs on fundraising, business planning and technology transfer. She brings experience as a Technology Transfer Manager at Cambridge Enterprise, University of Cambridge, where she assessed and marketed life science technologies, negotiated licences, and spun-out companies. She was responsible for technology transfer at the University of Cambridge for the Cambridge-MIT Institute. In her five years at the seed capital firm, Cambridge Research and Innovation, she identified and invested in early-stage technologies. Miranda co-founded Cambridge Network with Hermann Hauser.

Miranda studied Natural Sciences at the University of Cambridge and has a Diploma from the Chartered Institute of Management Accountants. She is a Fellow of the Linnean Society and has edited eight science books.

At AetoSense, we are on a mission to revolutionize the way buildings breathe. Our commitment lies in enhancing air quality for occupants, all while optimizing energy consumption.

We recognize the critical impact of airborne particles on health and energy efficiency, and our innovative solutions are designed to address these challenges head-on.

Our ground breaking Mini-CPC technology empowers HVAC retailers, manufacturers and others to minimize the presence of small particles in the air. By harnessing real-time data, our system enables you to optimize the amount of conditioned air recycled within a building, reducing energy consumption and environmental impact.

Asothia is the first AI-powered matching tool for biomedical researchers and funders.
We believe that the best research needs smarter, easier access to funding.

In our time at the University of Cambridge and Oxford, we noticed that researchers around us were spending most of their time looking and applying for grants. Studies have shown that researchers today spend as much as 50 per cent of their time applying for grants, and only a third of their time on research. We, along with our community of researchers, believe that this is having detrimental effects on scientific innovation.

By harnessing intelligent technologies, we are radically simplifying the process of applying for research funding. Our matching tool brings eligible, up-to-date funding opportunities straight to researchers and helps funders find new, highly talented researchers across the UK. The goal: giving Early Career Researchers back their time to focus on the science.

FinCrime Dynamics allows financial institutions to create their own synthetic data sets
enriched with customised financial crime simulations by using our product Synthetizor®.

This enriched data can then be freely used to test, measure and improve compliance controls (such as transaction monitoring systems) without the privacy constraints of real client data.
Synthetic data helps mitigate the data privacy concerns when using real private data. Synthetic data retains the analytical qualities of real data but cannot be traced back to the original source, unlike anonymised data.

We are a University of Cambridge spin out, founded on the pioneering research in
engineering nanomaterials at the Department of Chemical Engineering and Biotechnology.

Vector Bioscience develops a machine-learning empowered drug delivery platform. We are dedicated to transforming oncology treatments with our cargo-agnostic technology. Our precision-targeted delivery minimizes side effects with a higher uptake and slow release. By tailoring delivery, we achieve high local concentrations of traditionally difficult-to-formulate therapeutics.

At Biiah we believe in the untapped power of the human spirit. It is through music that it can be used as a force for good.

Our products and programmes build personal strength and resilient communities by encouraging the exploration of making sound.

Making music is an intrinsic part of the human experience and so it is our mission to empower millions to take better control of their health and improve their quality of life through music.

We deliver in-person and online music sessions for business, charities and organisations across the UK.

We work with you to understand your business and HR priorities, then build a programme tailored to your goals.

We are a global, interdisciplinary team of world-class scientists, psychologists and engineers, as well as experienced and passionate new-tech entrepreneurs. We were brought together to deliver digital healthcare solutions at the forefront of innovation for oncology.

In constant search for new solutions, our mission is to improve existing mental health care in the field by bridging the respective gaps as well as addressing emerging challenges and needs of stakeholders across the system.

ScreenMe was started with the aim to create a space where women and their health needs
were listened to and heard, but also solved.

We as women are taught and treated as if our uncomfortable symptoms, hormonal changes, and struggles are just “part of being female”. This means that we are mistreated, dismissed, and ultimately put at risk by our own healthcare system.

ScreenMe is putting an end to this. By offering personalised advice, care, recommendations and much more, we are able to understand you as an individual. Our experts listen, and work with you to construct easy-to-follow plans that actually fit your needs, lifestyle and goals. Ultimately, we empower you to take back control of your health – something you never should have lost.

We are biotechnology B2B cultured meat startup based in the University of Cambridge.

We are engineering a scalable, end-to-end ecosystem for Cultured Meat production, including specialist processes, enabling technologies, software, hardware and raw materials to democratize access to sustainable food and help tackle some of the world’s biggest sustainability and food security challenges.

CST bridges the gap between physical and mental health services and addresses wellbeing in a new way. We encourage individuals and groups to think about how to strengthen their mind, body and breath daily and provide them with the knowledge and tools to do so. We are medically backed and evidence based in everything we offer. From self help strategies for our mindset to quick access to talking therapy with experienced therapists, from at-home workouts to personal training and coaching, from guided meditations to one-to-one breath work courses.

CMR Surgical is a global medical devices company dedicated to transforming surgery with Versius®, a next-generation surgical robot.

CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable.

With Versius, we are on a mission to redefine the surgical robotics market with practical, innovative technology and data that can improve surgical care.

eScent is a pre-product, pre-revenue company that is building a small discreet wearable scent intervention worn to combat mid-moderate anxiety. eScent delivers evidenced- based essential oils (e.g. lavender and neroli) in response to biofeedback. Protected by 5 patents and a UK trademark, eScent’s smart liquid dispenser interfaces with worn biometric and contextual sensors to create an actionable ‘Scent Bubble®’ effect. The company was founded to commercialise Dr Tillotson’s design research from Central Saint Martins (UAL).

Water Sensitive Cambridge is on a mission to get rain back into the ground close to where it falls. We will do this by retrofitting rain gardens and other sustainable drainage features near highways using existing green spaces or creating new ones.

The benefits to nature are numerous, such as biodiversity and giving water support for existing green infrastructure (tree plantings, low traffic neighbourhoods, verges), but also softens the built landscape and creates cooler and more pleasant streets. These features also improve the quality and flow of rivers, by filtering, sinking and slowing the flow of water.

Noesis Therapeutics is a scalable platform technology solution for drug developers in the neurological and neurodegenerative disease space, generating SaaS revenue. We have developed an in-silico model of whole-brain network dysfunction in disorders such as Lewy-Body dementia, Alzheimer’s disease and epilepsy. The model is trained using proprietary patient data with our team know-how of computational clinical neuroscience and artificial intelligence.

Assisterr offers a multichannel developer support solution designed to deliver best-in-class tech support while reducing the need for manual labour and helping to improve the general developer experience.